Skip to content
Delayed ~15 min

HUM Humana

Permanent stock page ↗

Health Care · S&P 500

Next earnings: not announced yet

What 33 analyst firms say about Humana: their latest ratings, price targets and how far the stock is from them. How it works

433.74 USD+21.95 (+5.33%) today
Price as of 6 Nov 16:02 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+8.3%to the avg target 469.74 USD+36.00 USD
Buy 22 · Hold 10 · Sell 1

33 rated views · 34 analyst/firm records · 33 firms

Latest report13 Oct 2026avg report date 25 Aug
Target rangeLowest to highest analyst target, not a forecast

Radar score

  • S&P 500 · Top Picks · 6MBelow the Radar threshold of 8042
  • S&P 500 · Safest consensus · 6MBelow the Radar threshold of 8048

Recent analyst activity · last 90 days

Our tracked history has 19 reports on HUM from 17 analyst firms in the last 90 days (33 firms in the past year).

Comparing each firm's latest target with its previous one: 7 raised their price target, 2 left it unchanged and 3 have their first observed target in the past year.

Ratings, latest available report against the previous one: 2 upgrades and 0 downgrades.

Latest observed target change: Mizuho raised its target from $390.00 (set 8 Jun 2026) to $495.00 on 13 Oct 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
ArgusDavid A ToungHold8 Oct 2026—
BairdMichael HaBuy9 Oct 2026596.00 USD
Bank of America SecuritiesKevin FischbeckBuy29 Jul 2026500.00 USD
BarclaysAndrew MokBuy9 Oct 2026582.00 USD
BernsteinLance A WilkesBuy14 Aug 2026425.00 USD
Cantor FitzgeraldSarah JamesBuy7 Oct 2026460.00 USD
CitigroupUnnamed analystBuy9 Oct 2026—
Deutsche BankGeorge HillHold30 Jul 2026—
Evercore ISIElizabeth AndersonBuy29 Jul 2026480.00 USD
Goldman SachsScott FidelSell30 Jul 2026280.00 USD
GuggenheimJason CassorlaBuy30 Jul 2026471.00 USD
HSBCUnnamed analystHold30 Jul 2026—
JefferiesDavid H WindleyBuy31 Jul 2026420.00 USD
JPMorganLisa GillHold10 Aug 2026393.00 USD
KeyBanc Capital MarketsMatthew GillmorHold1 Jul 2026—
Lake Street Capital MarketsUnnamed analystBuy30 Jul 2026—
Leerink PartnersWhit MayoBuy30 Jul 2026513.00 USD
MizuhoAnn HynesBuy13 Oct 2026495.00 USD
Monness Crespi & HardtUnnamed analystBuy9 Oct 2026—
Morgan StanleyErin WrightBuy9 Oct 2026—
NeedhamUnnamed analystBuy20 May 2026—
OppenheimerMichael WiederhornBuy12 Oct 2026525.00 USD
Piper SandlerJessica TassanBuy30 Jul 2026463.00 USD
Raymond JamesJohn RansomBuy12 Oct 2026520.00 USD
Raymond JamesParker SnureBuy12 Oct 2026520.00 USD
RBC Capital MarketsBen HendrixHold9 Jul 2026415.00 USD
TD CowenRyan LangstonHold31 Jul 2026370.00 USD
TruistDavid MacDonaldHold12 Oct 2026475.00 USD
UBSA.J. RiceHold12 Oct 2026495.00 USD
Weiss RatingsUnnamed analyst—14 Aug 2026—
Wells FargoStephen BaxterBuy13 Jul 2026502.00 USD
William BlairUnnamed analystBuy20 May 2026—
Wolfe ResearchJustin LakeBuy4 Jun 2026450.00 USD
Data feed RESEARCHResearch TeamHold11 Aug 2026454.00 USD

Partial coverage · checked 6 Nov (6 Nov 2026, 03:56 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.